Flgf The new marketplaces connecting school and work
In the age of generative AI, when chatbots can provide detailed answers to que
jordan stions based on content pulled from the internet, the line between fair use and plagiarism, and between routine web scraping and unethical summarization, is a thin one.Perplexity AI is a startup that combines a search engine with a large language model that generates answers with detailed responses, rather than just links. Unlike OpenAI s ChatGPT and Anthropic s Claude, Perplexity doesn t train its own foundational AI models, instead using open or commercially a
nike airforce vailable ones to take the information it gathers from the internet and translate that into answers.But a series of accusations in June suggests the startup s approach borders on being uneth
jordan4 ical. Forbes called out Perplexity for allegedly plagiarizing one of its news articles in the startup s beta Perplexity Pages feature. And Wired has accused Perplexity of illicitly scraping its website, along with other sites.Perplexity, which as of April was working Dtlr Solving entertainment s globalization problem with AI and ML
The round is le
adidas campus red d by Episode1 Ventures, alongside Seedcamp, Cambridge Enterprise, January Ventures and several Europe and U.S.-bas
salomon mujer ed angel investors. It adds to 拢500,000 in pre-seed funding from 2018.Sano Genetics says part of the new capital will be to fund free at-home DNA testing kits for 3,000 people affected by Long COVID. It will also further invest in the development of its tech platform and grow the team.Founded in 2017 by Charlotte Guzzo, Patrick Short and William Jones after they met at Cambridge University
salomon x ultra while studying genomics as postgrads, Sano Genetics has built what it describes as a private-by-design tech platform to help patients take part in medical research and clinical trials. This includes at-home genetic testing capabilities, and is seeing the company support research into multiple sclerosis, ankylosing spondylitis, NAFLD and ulcerative colitis2, with a research programme for Parkinson disease on the agenda for later in 2021. For participant
